Health Care [ 12/12 ] | Health Care Providers & Services [ 46/74 ]
NYSE | Common Stock
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States.
The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other.
It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.
The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services.
In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations.
Further, the company is involved in the National Government Services business.
The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names.
The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022.
Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Jul 17, 24 | 10.12 Increased by +11.95% | 10.01 Increased by +1.10% |
| Apr 18, 24 | 10.64 Increased by +12.47% | 10.53 Increased by +1.04% |
| Jan 24, 24 | 5.62 Increased by +7.46% | 5.64 Decreased by -0.35% |
| Oct 18, 23 | 8.99 Increased by +19.39% | 8.44 Increased by +6.52% |
| Jul 19, 23 | 9.04 Increased by +12.44% | 8.80 Increased by +2.73% |
| Apr 19, 23 | 9.46 Increased by +14.67% | 9.26 Increased by +2.16% |
| Jan 25, 23 | 5.23 Increased by +1.75% | 5.19 Increased by +0.77% |
| Oct 19, 22 | 7.53 Increased by +10.90% | 7.15 Increased by +5.31% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 24 | 45.15 B Increased by +5.36% | 1.02 B Decreased by -21.18% | Increased by +2.25% Decreased by -25.19% |
| Jun 30, 24 | 43.65 B Decreased by -0.06% | 2.30 B Increased by +24.12% | Increased by +5.27% Increased by +24.20% |
| Mar 31, 24 | 42.58 B Increased by +0.96% | 2.25 B Increased by +12.08% | Increased by +5.28% Increased by +11.01% |
| Dec 31, 23 | 42.65 B Increased by +9.37% | 856.00 M Decreased by -12.38% | Increased by +2.01% Decreased by -19.89% |
| Sep 30, 23 | 42.85 B Increased by +7.29% | 1.29 B Decreased by -20.09% | Increased by +3.01% Decreased by -25.51% |
| Jun 30, 23 | 43.67 B Increased by +13.05% | 1.85 B Increased by +12.30% | Increased by +4.24% Decreased by -0.66% |
| Mar 31, 23 | 42.17 B Increased by +10.70% | 2.00 B Increased by +12.65% | Increased by +4.75% Increased by +1.76% |
| Dec 31, 22 | 38.99 B Increased by +11.78% | 977.00 M Decreased by -13.16% | Increased by +2.51% Decreased by -22.31% |